Genetic characterization of breast cancer and implications for clinical management

被引:24
作者
Geyer, Felipe C. [1 ]
Lopez-Garcia, Maria A. [1 ]
Lambros, Maryou B. [1 ]
Reis-Filho, Jorge S. [1 ]
机构
[1] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Mol Pathol Lab, London SW3 6JB, England
关键词
microarray; comparative genomic hybridization; gene expression; biomarker; therapeutic target; TOPOISOMERASE-II-ALPHA; IN-SITU HYBRIDIZATION; COPY NUMBER ALTERATIONS; TRIPLE-NEGATIVE TUMORS; BASAL-LIKE SUBTYPE; DNA-REPAIR DEFECT; ESTROGEN-RECEPTOR; E-CADHERIN; ADJUVANT CHEMOTHERAPY; LOBULAR CARCINOMA;
D O I
10.1111/j.1582-4934.2009.00906.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Breast cancer is a genetic disease caused by the accumulation of mutations in neoplastic cells. In the last few years, high-throughput microarray-based molecular analysis has provided increasingly more coherent information about the genetic aberrations in breast cancer. New biomarkers and molecular techniques are slowly becoming part of the diagnostic and prognostic armamentarium available for pathologists and oncologists to tailor the therapy for breast cancer patients. In this review, we will focus on the contribution of breast cancer somatic genetics to our understanding of breast cancer biology and its impact on breast cancer patient management.
引用
收藏
页码:4090 / 4103
页数:14
相关论文
共 172 条
[1]   Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Reis-Filho, Jorge S. ;
Lee, Andrew H. S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (04) :513-523
[2]   High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Lee, Andrew H. S. ;
Reis-Filho, Jorge S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (03) :417-426
[3]   Technology Insight: tuning into the genetic orchestra using microarrays - limitations of DNA microarrays in clinical practice [J].
Abdullah-Sayani, Arnbreen ;
Bueno-de-Mesquita, Jolien M. ;
van de Vijver, Marc J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (09) :501-516
[4]   Integrated profiling of basal and luminal breast cancers [J].
Adelaide, Jose ;
Finetti, Pascal ;
Bekhouche, Ismahane ;
Repellini, Laetitia ;
Geneix, Jeannine ;
Sircoulomb, Fabrice ;
Jauffret, Emmanuelle Charafe ;
Cervera, Nathalie ;
Desplans, Jerome ;
Parzy, Daniel ;
Schoenmakers, Eric ;
Viens, Patrice ;
Jacquemier, Jocelyne ;
Birnbaum, Daniel ;
Bertucci, Francois ;
Chaffanet, Max .
CANCER RESEARCH, 2007, 67 (24) :11565-11575
[5]   DNA arrays as predictors of efficacy of adjuvant/neoadjuvant chemotherapy in breast cancer patients: Current data and issues on study design [J].
Andre, Fabrice ;
Mazouni, Chafika ;
Hortobagyi, Gabriel N. ;
Pusztai, Lajos .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02) :197-204
[6]   Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy [J].
Andre, Fabrice ;
Pusztai, Lajos .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (11) :621-632
[7]   Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array [J].
Andre, Fabrice ;
Job, Bastien ;
Dessen, Philippe ;
Tordai, Attila ;
Michiels, Stefan ;
Liedtke, Cornelia ;
Richon, Catherine ;
Yan, Kai ;
Wang, Bailang ;
Vassal, Gilles ;
Delaloge, Suzette ;
Hortobagyi, Gabriel N. ;
Symmans, W. Fraser ;
Lazar, Vladimir ;
Pusztai, Lajos .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :441-451
[8]   Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER) [J].
不详 .
LANCET ONCOLOGY, 2007, 8 (12) :1079-1087
[9]   Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome [J].
Arpino, G ;
Bardou, VJ ;
Clark, GM ;
Elledge, RM .
BREAST CANCER RESEARCH, 2004, 6 (03) :R149-R156
[10]   Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines [J].
Arriola, Edurne ;
Marchio, Caterina ;
Tan, David Sp ;
Drury, Suzanne C. ;
Lambros, Maryou B. ;
Natrajan, Rachael ;
Rodriguez-Pinilla, Socorro Maria ;
Mackay, Alan ;
Tamber, Narinder ;
Fenwick, Kerry ;
Jones, Chris ;
Dowsett, Mitch ;
Ashworth, Alan ;
Reis-Filho, Jorge S. .
LABORATORY INVESTIGATION, 2008, 88 (05) :491-503